US · guidance
CMS Pub. 100-04, ch. 17, § 80.10
Hospitals Billing for Epoetin Alfa (EPO) and Darbepoetin Alfa
(Aranesp) for Non-ESRD Patients
(Rev. 1412, Issued: 01-11-08, Effective: 01-01-08, Implementation: 04-07-08)
NOTE: For EPO and Aranesp billing instructions for beneficiaries with ESRD, see the
Claims Processing Manual, Chapter 8, sections 60.4 and 60.7.
For patients with chronic renal failure who are not yet on a regular course of dialysis,
EPO and Aranesp administered in a hospital and billed as an outpatient service on type of
bill 13x or inpatient Part B bill type 12x are paid under the Outpatient Prospective
Payment System (OPPS). Non-OPPS hospitals are paid on reasonable charges.
Hospitals report charges under revenue code 0636. For EPO, hospitals report charges
under revenue code 0636 with HCPCS code J0885 effective January 1, 2006. Aranesp is
reported with HCPCS code J0881 effective January 1, 2006.
History
(Rev. 1412, Issued: 01-11-08, Effective: 01-01-08, Implementation: 04-07-08)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
f6d098d68de8a554678548d793dbaf2c95310716b9714857a1e18c4f5da01067
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.